Oramed Pharm's total assets for Q2 2026 were $369.64M, an increase of 60.11% from the previous quarter. IL:ORMP total liabilities were $52.17M for the fiscal quarter, a 67.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.